Oncology Pharma Inc. (ONPH) Research

Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019. Its operations are based in San Francisco, California.

Market snapshot

Symbol
ONPH
Price
$0.05
Day change
-28.29%
Market cap
$1.4M
P/E ratio
-708.71x
52-week range
0.0001-0.364
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Ampio Pharmaceuticals, Inc. (AMPE)
  • Arno Therapeutics, Inc. (ARNI)
  • Better Therapeutics, Inc. (BTTX)
  • Baudax Bio, Inc. (BXRXQ)
  • Calithera Biosciences, Inc. (CALA)
  • InnerScope Hearing Technologies, Inc. (INND)
  • Innovation1 Biotech Inc. (IVBT)
  • Panacos Pharmaceuticals, Inc. (PANC)

Open Oncology Pharma Inc. (ONPH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.